Daxxify: the 6-month neuromodulator — how it differs from Botox, Dysport, and Xeomin
A complete guide to Daxxify (daxibotulinumtoxinA) — the FDA-approved neuromodulator that lasts up to 6 months, how its peptide-enhanced formulation differs, candidacy, and what to expect.
· By MedSpot Editorial · 5 min read
Daxxify (daxibotulinumtoxinA-lanm), made by Revance Therapeutics, is the newest FDA-approved neuromodulator in the US. Its key differentiator: it lasts significantly longer than Botox, Dysport, or Xeomin — up to 6 months in many patients. Here's what's different and who benefits.
What is Daxxify?
Daxxify is a botulinum toxin type A neuromodulator — it works the same way Botox works at the neuromuscular junction, blocking acetylcholine release to temporarily relax targeted muscles. What's different is how long the toxin remains at the injection site.
FDA approval: Daxxify received FDA approval in September 2022 for moderate-to-severe glabellar lines (the "11s" between the eyebrows) in adults. It is the first neuromodulator to be approved in the US since Xeomin in 2010.
What makes it last longer: the PRTX peptide
Traditional neuromodulators (Botox, Dysport, Xeomin) use human serum albumin as a stabilizing protein that helps keep the toxin stable in formulation. Daxxify uses a proprietary stabilizing peptide (RTP004, abbreviated in clinical materials as "PRTX") instead of human albumin.
The proposed mechanism of longer duration: The peptide is thought to enhance binding of the toxin at the neuromuscular junction, leading to more durable effects. The exact mechanism isn't fully characterized — the prolonged duration is an observed clinical outcome from trials.
No human or animal-derived proteins: Because it doesn't use human serum albumin, Daxxify is formulated without human or animal-derived proteins. This is a potential advantage for patients with albumin sensitivities or specific ethical preferences, though adverse events related to albumin in traditional neuromodulators are extremely rare.
How long does Daxxify last?
The pivotal clinical trials (SAKURA 1 and SAKURA 2) showed:
- Median duration: ~24 weeks (6 months) for the glabellar lines indication
- Response at 6 months: Approximately 47% of patients still had none or minimal glabellar lines at 24 weeks in the phase 3 trial
- Response variability: Some patients see duration closer to 4–5 months; a subset exceeds 6 months
By comparison:
| Product | Typical duration |
|---|---|
| Botox | 3–4 months |
| Dysport | 3–4 months |
| Xeomin | 3–4 months |
| Daxxify | 4.5–6 months (most patients) |
What Daxxify is FDA-approved for
Currently: glabellar lines (the 11s) only. Revance is pursuing additional indications including cervical dystonia (a medical use) and potentially other cosmetic areas.
Off-label use: Like all neuromodulators, Daxxify can be used off-label for other areas — forehead lines, crow's feet, lip flip, brow lift, masseter reduction, etc. Injectors experienced with neuromodulators can apply similar technique principles. However, the clinical trial data on duration and dosing outside of glabellar lines is limited compared to Botox.
Dosing: how is it different from Botox?
Daxxify is not unit-for-unit interchangeable with Botox. The units are specific to Daxxify — they are not the same unit as a "Botox unit" (which is measured differently from Dysport units as well).
Typical glabellar doses in clinical trials:
- 40 units (lower dose) and 60 units of Daxxify were studied
- 40 units showed strong response; 60 units produced marginally better results
An experienced injector will determine the appropriate dose — patients should not assume a conversion ratio from their previous Botox dosing.
Who is a good candidate for Daxxify?
Best suited for:
- Patients who metabolize Botox quickly (3 months or less)
- Patients with busy schedules who want fewer annual appointments
- Patients seeking longer-lasting glabellar results specifically
- Patients interested in a human albumin-free neuromodulator
Less suited for:
- First-time neuromodulator patients — the longer duration means any undesired effect (brow drop, asymmetry) will persist longer. New patients are better served starting with a shorter-acting product to establish their ideal dose.
- Patients with ptosis history or brow ptosis risk
- Patients who prefer to adjust dosing frequently
Onset: faster or slower than Botox?
Onset data from trials shows Daxxify acts quickly — many patients notice effect within 1–2 days, with full effect by 1 week. Some studies suggest faster initial onset than Botox, though this is patient-variable and not a primary differentiator.
Cost
Daxxify is typically priced per unit, like Botox — but because each "Daxxify unit" is a different concentration, direct cost comparison isn't straightforward. In practice, expect to pay 20–30% more per treatment than Botox/Dysport, offset by needing fewer treatments per year.
Example rough math:
- Botox glabellar: $400–$600 per treatment × 3 treatments/year = $1,200–$1,800/year
- Daxxify glabellar: $550–$800 per treatment × 2 treatments/year = $1,100–$1,600/year
The per-year cost often comes out similar or slightly lower for Daxxify — the main value is fewer appointments, not necessarily less total spend.
Switching from Botox to Daxxify
If you're an established Botox patient interested in trying Daxxify:
- Choose a provider experienced with Daxxify dosing (different dose units from Botox)
- Start with one treatment area (glabellar) before switching all areas
- Be prepared for the longer duration — if the result is subtly different from your ideal, you'll live with it longer before you can course-correct
Side effects
The safety profile in trials is comparable to Botox:
- Injection site reactions: Headache (most common), injection site pain, bruising
- Facial: Eyelid ptosis (drooping), brow ptosis — same risk as Botox from glabellar injection
- No unique safety signals identified in trials compared to other approved neuromodulators
Questions to ask before booking
- Are you experienced specifically with Daxxify dosing and unit conversion from Botox?
- For my treatment areas (especially any off-label), how does the duration affect dosing strategy?
- Given that I'm a new neuromodulator patient, do you recommend starting with Botox first to establish my ideal dose?
- What do you see as the realistic duration for my muscle strength and metabolism?
- What is the total annual cost of Daxxify vs. Botox for my treatment plan?
Looking for an injector offering Daxxify? Browse injectable providers on MedSpot →